Research and analysis

Improving information supplied with gabapentinoids (pregabalin/gabapentin), benzodiazepines and z-drugs

Public Assessment Report on improving information regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 8 January 2026

Documents

Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs

PDF, 601 KB, 42 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents the MHRA’s review of safety data for gabapentinoids, benzodiazepines and z-drugs and expert advice on management of risks, as advised by the CHM.

Published 8 January 2026